Global Live Brucellosis Vaccine Supply, Demand and Key Producers, 2024-2030

Page: 151

Published Date: 13 Dec 2024

Category: Agriculture

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Live Brucellosis Vaccine market size is expected to reach $ 253 million by 2030, rising at a market growth of 4.1% CAGR during the forecast period (2024-2030).

Live Brucellosis Vaccine is a kind of vaccine used to prevent brucellosis, which is also known as Malta fever or undulant fever. It is a live attenuated vaccine prepared from weakened strains of Brucella bacteria. The attenuated Brucella strains in the live vaccine still retain certain antigenicity, which can stimulate the body's immune system to produce a relatively strong immune response, inducing the production of specific antibodies and cell-mediated immune responses, thereby providing effective protection for the body to prevent the occurrence of brucellosis. The attenuated strains in the live vaccine can replicate to a limited extent in the body, allowing the body's immune system to be continuously stimulated by antigens, resulting in more long-lasting immunity and extending the duration of immune protection.

This report studies the global Live Brucellosis Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Live Brucellosis Vaccine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Live Brucellosis Vaccine that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Live Brucellosis Vaccine total production and demand, 2019-2030, (K Units)
Global Live Brucellosis Vaccine total production value, 2019-2030, (USD Million)
Global Live Brucellosis Vaccine production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units), (based on production site)
Global Live Brucellosis Vaccine consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Live Brucellosis Vaccine domestic production, consumption, key domestic manufacturers and share
Global Live Brucellosis Vaccine production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Live Brucellosis Vaccine production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Live Brucellosis Vaccine production by Application, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
This report profiles key players in the global Live Brucellosis Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CZ Vaccines, MSD, Ceva, Colorado Serum, Tecnovax, Syva, Shchelkovo Biocombinat, Jinyu Baoling, Biovet, CAVAC, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Live Brucellosis Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Live Brucellosis Vaccine Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Live Brucellosis Vaccine Market, Segmentation by Type:
    Strain RB-51
    Strain S19
    Strain S2
    Strain A19
    Strain Rev. I

Global Live Brucellosis Vaccine Market, Segmentation by Application:
    Cattle
    Sheep
    Pig
    Others

Companies Profiled:
    CZ Vaccines
    MSD
    Ceva
    Colorado Serum
    Tecnovax
    Syva
    Shchelkovo Biocombinat
    Jinyu Baoling
    Biovet
    CAVAC
    VETAL
    Indian Immunologicals
    Dollvet
    Hester Biosciences
    Qilu Animal Health
    Auleon Biologicals

Key Questions Answered:
1. How big is the global Live Brucellosis Vaccine market?
2. What is the demand of the global Live Brucellosis Vaccine market?
3. What is the year over year growth of the global Live Brucellosis Vaccine market?
4. What is the production and production value of the global Live Brucellosis Vaccine market?
5. Who are the key producers in the global Live Brucellosis Vaccine market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Live Brucellosis Vaccine Introduction
    1.2 World Live Brucellosis Vaccine Supply & Forecast
        1.2.1 World Live Brucellosis Vaccine Production Value (2019 & 2023 & 2030)
        1.2.2 World Live Brucellosis Vaccine Production (2019-2030)
        1.2.3 World Live Brucellosis Vaccine Pricing Trends (2019-2030)
    1.3 World Live Brucellosis Vaccine Production by Region (Based on Production Site)
        1.3.1 World Live Brucellosis Vaccine Production Value by Region (2019-2030)
        1.3.2 World Live Brucellosis Vaccine Production by Region (2019-2030)
        1.3.3 World Live Brucellosis Vaccine Average Price by Region (2019-2030)
        1.3.4 North America Live Brucellosis Vaccine Production (2019-2030)
        1.3.5 Europe Live Brucellosis Vaccine Production (2019-2030)
        1.3.6 China Live Brucellosis Vaccine Production (2019-2030)
        1.3.7 Japan Live Brucellosis Vaccine Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Live Brucellosis Vaccine Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Live Brucellosis Vaccine Major Market Trends

2 Demand Summary
    2.1 World Live Brucellosis Vaccine Demand (2019-2030)
    2.2 World Live Brucellosis Vaccine Consumption by Region
        2.2.1 World Live Brucellosis Vaccine Consumption by Region (2019-2024)
        2.2.2 World Live Brucellosis Vaccine Consumption Forecast by Region (2025-2030)
    2.3 United States Live Brucellosis Vaccine Consumption (2019-2030)
    2.4 China Live Brucellosis Vaccine Consumption (2019-2030)
    2.5 Europe Live Brucellosis Vaccine Consumption (2019-2030)
    2.6 Japan Live Brucellosis Vaccine Consumption (2019-2030)
    2.7 South Korea Live Brucellosis Vaccine Consumption (2019-2030)
    2.8 ASEAN Live Brucellosis Vaccine Consumption (2019-2030)
    2.9 India Live Brucellosis Vaccine Consumption (2019-2030)

3 World Manufacturers Competitive Analysis
    3.1 World Live Brucellosis Vaccine Production Value by Manufacturer (2019-2024)
    3.2 World Live Brucellosis Vaccine Production by Manufacturer (2019-2024)
    3.3 World Live Brucellosis Vaccine Average Price by Manufacturer (2019-2024)
    3.4 Live Brucellosis Vaccine Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Live Brucellosis Vaccine Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Live Brucellosis Vaccine in 2023
        3.5.3 Global Concentration Ratios (CR8) for Live Brucellosis Vaccine in 2023
    3.6 Live Brucellosis Vaccine Market: Overall Company Footprint Analysis
        3.6.1 Live Brucellosis Vaccine Market: Region Footprint
        3.6.2 Live Brucellosis Vaccine Market: Company Product Type Footprint
        3.6.3 Live Brucellosis Vaccine Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Live Brucellosis Vaccine Production Value Comparison
        4.1.1 United States VS China: Live Brucellosis Vaccine Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Live Brucellosis Vaccine Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Live Brucellosis Vaccine Production Comparison
        4.2.1 United States VS China: Live Brucellosis Vaccine Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Live Brucellosis Vaccine Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Live Brucellosis Vaccine Consumption Comparison
        4.3.1 United States VS China: Live Brucellosis Vaccine Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Live Brucellosis Vaccine Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Live Brucellosis Vaccine Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Live Brucellosis Vaccine Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Live Brucellosis Vaccine Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Live Brucellosis Vaccine Production (2019-2024)
    4.5 China Based Live Brucellosis Vaccine Manufacturers and Market Share
        4.5.1 China Based Live Brucellosis Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Live Brucellosis Vaccine Production Value (2019-2024)
        4.5.3 China Based Manufacturers Live Brucellosis Vaccine Production (2019-2024)
    4.6 Rest of World Based Live Brucellosis Vaccine Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Live Brucellosis Vaccine Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Live Brucellosis Vaccine Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Live Brucellosis Vaccine Production (2019-2024)

5 Market Analysis by Type
    5.1 World Live Brucellosis Vaccine Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Strain RB-51
        5.2.2 Strain S19
        5.2.3 Strain S2
        5.2.4 Strain A19
        5.2.5 Strain Rev. I
    5.3 Market Segment by Type
        5.3.1 World Live Brucellosis Vaccine Production by Type (2019-2030)
        5.3.2 World Live Brucellosis Vaccine Production Value by Type (2019-2030)
        5.3.3 World Live Brucellosis Vaccine Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Live Brucellosis Vaccine Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Cattle
        6.2.2 Sheep
        6.2.3 Pig
        6.2.4 Others
    6.3 Market Segment by Application
        6.3.1 World Live Brucellosis Vaccine Production by Application (2019-2030)
        6.3.2 World Live Brucellosis Vaccine Production Value by Application (2019-2030)
        6.3.3 World Live Brucellosis Vaccine Average Price by Application (2019-2030)

7 Company Profiles
    7.1 CZ Vaccines
        7.1.1 CZ Vaccines Details
        7.1.2 CZ Vaccines Major Business
        7.1.3 CZ Vaccines Live Brucellosis Vaccine Product and Services
        7.1.4 CZ Vaccines Live Brucellosis Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 CZ Vaccines Recent Developments/Updates
        7.1.6 CZ Vaccines Competitive Strengths & Weaknesses
    7.2 MSD
        7.2.1 MSD Details
        7.2.2 MSD Major Business
        7.2.3 MSD Live Brucellosis Vaccine Product and Services
        7.2.4 MSD Live Brucellosis Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 MSD Recent Developments/Updates
        7.2.6 MSD Competitive Strengths & Weaknesses
    7.3 Ceva
        7.3.1 Ceva Details
        7.3.2 Ceva Major Business
        7.3.3 Ceva Live Brucellosis Vaccine Product and Services
        7.3.4 Ceva Live Brucellosis Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Ceva Recent Developments/Updates
        7.3.6 Ceva Competitive Strengths & Weaknesses
    7.4 Colorado Serum
        7.4.1 Colorado Serum Details
        7.4.2 Colorado Serum Major Business
        7.4.3 Colorado Serum Live Brucellosis Vaccine Product and Services
        7.4.4 Colorado Serum Live Brucellosis Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Colorado Serum Recent Developments/Updates
        7.4.6 Colorado Serum Competitive Strengths & Weaknesses
    7.5 Tecnovax
        7.5.1 Tecnovax Details
        7.5.2 Tecnovax Major Business
        7.5.3 Tecnovax Live Brucellosis Vaccine Product and Services
        7.5.4 Tecnovax Live Brucellosis Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Tecnovax Recent Developments/Updates
        7.5.6 Tecnovax Competitive Strengths & Weaknesses
    7.6 Syva
        7.6.1 Syva Details
        7.6.2 Syva Major Business
        7.6.3 Syva Live Brucellosis Vaccine Product and Services
        7.6.4 Syva Live Brucellosis Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Syva Recent Developments/Updates
        7.6.6 Syva Competitive Strengths & Weaknesses
    7.7 Shchelkovo Biocombinat
        7.7.1 Shchelkovo Biocombinat Details
        7.7.2 Shchelkovo Biocombinat Major Business
        7.7.3 Shchelkovo Biocombinat Live Brucellosis Vaccine Product and Services
        7.7.4 Shchelkovo Biocombinat Live Brucellosis Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Shchelkovo Biocombinat Recent Developments/Updates
        7.7.6 Shchelkovo Biocombinat Competitive Strengths & Weaknesses
    7.8 Jinyu Baoling
        7.8.1 Jinyu Baoling Details
        7.8.2 Jinyu Baoling Major Business
        7.8.3 Jinyu Baoling Live Brucellosis Vaccine Product and Services
        7.8.4 Jinyu Baoling Live Brucellosis Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 Jinyu Baoling Recent Developments/Updates
        7.8.6 Jinyu Baoling Competitive Strengths & Weaknesses
    7.9 Biovet
        7.9.1 Biovet Details
        7.9.2 Biovet Major Business
        7.9.3 Biovet Live Brucellosis Vaccine Product and Services
        7.9.4 Biovet Live Brucellosis Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 Biovet Recent Developments/Updates
        7.9.6 Biovet Competitive Strengths & Weaknesses
    7.10 CAVAC
        7.10.1 CAVAC Details
        7.10.2 CAVAC Major Business
        7.10.3 CAVAC Live Brucellosis Vaccine Product and Services
        7.10.4 CAVAC Live Brucellosis Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.10.5 CAVAC Recent Developments/Updates
        7.10.6 CAVAC Competitive Strengths & Weaknesses
    7.11 VETAL
        7.11.1 VETAL Details
        7.11.2 VETAL Major Business
        7.11.3 VETAL Live Brucellosis Vaccine Product and Services
        7.11.4 VETAL Live Brucellosis Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.11.5 VETAL Recent Developments/Updates
        7.11.6 VETAL Competitive Strengths & Weaknesses
    7.12 Indian Immunologicals
        7.12.1 Indian Immunologicals Details
        7.12.2 Indian Immunologicals Major Business
        7.12.3 Indian Immunologicals Live Brucellosis Vaccine Product and Services
        7.12.4 Indian Immunologicals Live Brucellosis Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.12.5 Indian Immunologicals Recent Developments/Updates
        7.12.6 Indian Immunologicals Competitive Strengths & Weaknesses
    7.13 Dollvet
        7.13.1 Dollvet Details
        7.13.2 Dollvet Major Business
        7.13.3 Dollvet Live Brucellosis Vaccine Product and Services
        7.13.4 Dollvet Live Brucellosis Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.13.5 Dollvet Recent Developments/Updates
        7.13.6 Dollvet Competitive Strengths & Weaknesses
    7.14 Hester Biosciences
        7.14.1 Hester Biosciences Details
        7.14.2 Hester Biosciences Major Business
        7.14.3 Hester Biosciences Live Brucellosis Vaccine Product and Services
        7.14.4 Hester Biosciences Live Brucellosis Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.14.5 Hester Biosciences Recent Developments/Updates
        7.14.6 Hester Biosciences Competitive Strengths & Weaknesses
    7.15 Qilu Animal Health
        7.15.1 Qilu Animal Health Details
        7.15.2 Qilu Animal Health Major Business
        7.15.3 Qilu Animal Health Live Brucellosis Vaccine Product and Services
        7.15.4 Qilu Animal Health Live Brucellosis Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.15.5 Qilu Animal Health Recent Developments/Updates
        7.15.6 Qilu Animal Health Competitive Strengths & Weaknesses
    7.16 Auleon Biologicals
        7.16.1 Auleon Biologicals Details
        7.16.2 Auleon Biologicals Major Business
        7.16.3 Auleon Biologicals Live Brucellosis Vaccine Product and Services
        7.16.4 Auleon Biologicals Live Brucellosis Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.16.5 Auleon Biologicals Recent Developments/Updates
        7.16.6 Auleon Biologicals Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Live Brucellosis Vaccine Industry Chain
    8.2 Live Brucellosis Vaccine Upstream Analysis
        8.2.1 Live Brucellosis Vaccine Core Raw Materials
        8.2.2 Main Manufacturers of Live Brucellosis Vaccine Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Live Brucellosis Vaccine Production Mode
    8.6 Live Brucellosis Vaccine Procurement Model
    8.7 Live Brucellosis Vaccine Industry Sales Model and Sales Channels
        8.7.1 Live Brucellosis Vaccine Sales Model
        8.7.2 Live Brucellosis Vaccine Typical Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Live Brucellosis Vaccine Production Value by Region (2019, 2023 and 2030) & (USD Million)
 Table 2. World Live Brucellosis Vaccine Production Value by Region (2019-2024) & (USD Million)
 Table 3. World Live Brucellosis Vaccine Production Value by Region (2025-2030) & (USD Million)
 Table 4. World Live Brucellosis Vaccine Production Value Market Share by Region (2019-2024)
 Table 5. World Live Brucellosis Vaccine Production Value Market Share by Region (2025-2030)
 Table 6. World Live Brucellosis Vaccine Production by Region (2019-2024) & (K Units)
 Table 7. World Live Brucellosis Vaccine Production by Region (2025-2030) & (K Units)
 Table 8. World Live Brucellosis Vaccine Production Market Share by Region (2019-2024)
 Table 9. World Live Brucellosis Vaccine Production Market Share by Region (2025-2030)
 Table 10. World Live Brucellosis Vaccine Average Price by Region (2019-2024) & (US$/Unit)
 Table 11. World Live Brucellosis Vaccine Average Price by Region (2025-2030) & (US$/Unit)
 Table 12. Live Brucellosis Vaccine Major Market Trends
 Table 13. World Live Brucellosis Vaccine Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
 Table 14. World Live Brucellosis Vaccine Consumption by Region (2019-2024) & (K Units)
 Table 15. World Live Brucellosis Vaccine Consumption Forecast by Region (2025-2030) & (K Units)
 Table 16. World Live Brucellosis Vaccine Production Value by Manufacturer (2019-2024) & (USD Million)
 Table 17. Production Value Market Share of Key Live Brucellosis Vaccine Producers in 2023
 Table 18. World Live Brucellosis Vaccine Production by Manufacturer (2019-2024) & (K Units)
 Table 19. Production Market Share of Key Live Brucellosis Vaccine Producers in 2023
 Table 20. World Live Brucellosis Vaccine Average Price by Manufacturer (2019-2024) & (US$/Unit)
 Table 21. Global Live Brucellosis Vaccine Company Evaluation Quadrant
 Table 22. World Live Brucellosis Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2023
 Table 23. Head Office and Live Brucellosis Vaccine Production Site of Key Manufacturer
 Table 24. Live Brucellosis Vaccine Market: Company Product Type Footprint
 Table 25. Live Brucellosis Vaccine Market: Company Product Application Footprint
 Table 26. Live Brucellosis Vaccine Competitive Factors
 Table 27. Live Brucellosis Vaccine New Entrant and Capacity Expansion Plans
 Table 28. Live Brucellosis Vaccine Mergers & Acquisitions Activity
 Table 29. United States VS China Live Brucellosis Vaccine Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 30. United States VS China Live Brucellosis Vaccine Production Comparison, (2019 & 2023 & 2030) & (K Units)
 Table 31. United States VS China Live Brucellosis Vaccine Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
 Table 32. United States Based Live Brucellosis Vaccine Manufacturers, Headquarters and Production Site (States, Country)
 Table 33. United States Based Manufacturers Live Brucellosis Vaccine Production Value, (2019-2024) & (USD Million)
 Table 34. United States Based Manufacturers Live Brucellosis Vaccine Production Value Market Share (2019-2024)
 Table 35. United States Based Manufacturers Live Brucellosis Vaccine Production (2019-2024) & (K Units)
 Table 36. United States Based Manufacturers Live Brucellosis Vaccine Production Market Share (2019-2024)
 Table 37. China Based Live Brucellosis Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
 Table 38. China Based Manufacturers Live Brucellosis Vaccine Production Value, (2019-2024) & (USD Million)
 Table 39. China Based Manufacturers Live Brucellosis Vaccine Production Value Market Share (2019-2024)
 Table 40. China Based Manufacturers Live Brucellosis Vaccine Production, (2019-2024) & (K Units)
 Table 41. China Based Manufacturers Live Brucellosis Vaccine Production Market Share (2019-2024)
 Table 42. Rest of World Based Live Brucellosis Vaccine Manufacturers, Headquarters and Production Site (State, Country)
 Table 43. Rest of World Based Manufacturers Live Brucellosis Vaccine Production Value, (2019-2024) & (USD Million)
 Table 44. Rest of World Based Manufacturers Live Brucellosis Vaccine Production Value Market Share (2019-2024)
 Table 45. Rest of World Based Manufacturers Live Brucellosis Vaccine Production, (2019-2024) & (K Units)
 Table 46. Rest of World Based Manufacturers Live Brucellosis Vaccine Production Market Share (2019-2024)
 Table 47. World Live Brucellosis Vaccine Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 48. World Live Brucellosis Vaccine Production by Type (2019-2024) & (K Units)
 Table 49. World Live Brucellosis Vaccine Production by Type (2025-2030) & (K Units)
 Table 50. World Live Brucellosis Vaccine Production Value by Type (2019-2024) & (USD Million)
 Table 51. World Live Brucellosis Vaccine Production Value by Type (2025-2030) & (USD Million)
 Table 52. World Live Brucellosis Vaccine Average Price by Type (2019-2024) & (US$/Unit)
 Table 53. World Live Brucellosis Vaccine Average Price by Type (2025-2030) & (US$/Unit)
 Table 54. World Live Brucellosis Vaccine Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 55. World Live Brucellosis Vaccine Production by Application (2019-2024) & (K Units)
 Table 56. World Live Brucellosis Vaccine Production by Application (2025-2030) & (K Units)
 Table 57. World Live Brucellosis Vaccine Production Value by Application (2019-2024) & (USD Million)
 Table 58. World Live Brucellosis Vaccine Production Value by Application (2025-2030) & (USD Million)
 Table 59. World Live Brucellosis Vaccine Average Price by Application (2019-2024) & (US$/Unit)
 Table 60. World Live Brucellosis Vaccine Average Price by Application (2025-2030) & (US$/Unit)
 Table 61. CZ Vaccines Basic Information, Manufacturing Base and Competitors
 Table 62. CZ Vaccines Major Business
 Table 63. CZ Vaccines Live Brucellosis Vaccine Product and Services
 Table 64. CZ Vaccines Live Brucellosis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 65. CZ Vaccines Recent Developments/Updates
 Table 66. CZ Vaccines Competitive Strengths & Weaknesses
 Table 67. MSD Basic Information, Manufacturing Base and Competitors
 Table 68. MSD Major Business
 Table 69. MSD Live Brucellosis Vaccine Product and Services
 Table 70. MSD Live Brucellosis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 71. MSD Recent Developments/Updates
 Table 72. MSD Competitive Strengths & Weaknesses
 Table 73. Ceva Basic Information, Manufacturing Base and Competitors
 Table 74. Ceva Major Business
 Table 75. Ceva Live Brucellosis Vaccine Product and Services
 Table 76. Ceva Live Brucellosis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 77. Ceva Recent Developments/Updates
 Table 78. Ceva Competitive Strengths & Weaknesses
 Table 79. Colorado Serum Basic Information, Manufacturing Base and Competitors
 Table 80. Colorado Serum Major Business
 Table 81. Colorado Serum Live Brucellosis Vaccine Product and Services
 Table 82. Colorado Serum Live Brucellosis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 83. Colorado Serum Recent Developments/Updates
 Table 84. Colorado Serum Competitive Strengths & Weaknesses
 Table 85. Tecnovax Basic Information, Manufacturing Base and Competitors
 Table 86. Tecnovax Major Business
 Table 87. Tecnovax Live Brucellosis Vaccine Product and Services
 Table 88. Tecnovax Live Brucellosis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 89. Tecnovax Recent Developments/Updates
 Table 90. Tecnovax Competitive Strengths & Weaknesses
 Table 91. Syva Basic Information, Manufacturing Base and Competitors
 Table 92. Syva Major Business
 Table 93. Syva Live Brucellosis Vaccine Product and Services
 Table 94. Syva Live Brucellosis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 95. Syva Recent Developments/Updates
 Table 96. Syva Competitive Strengths & Weaknesses
 Table 97. Shchelkovo Biocombinat Basic Information, Manufacturing Base and Competitors
 Table 98. Shchelkovo Biocombinat Major Business
 Table 99. Shchelkovo Biocombinat Live Brucellosis Vaccine Product and Services
 Table 100. Shchelkovo Biocombinat Live Brucellosis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 101. Shchelkovo Biocombinat Recent Developments/Updates
 Table 102. Shchelkovo Biocombinat Competitive Strengths & Weaknesses
 Table 103. Jinyu Baoling Basic Information, Manufacturing Base and Competitors
 Table 104. Jinyu Baoling Major Business
 Table 105. Jinyu Baoling Live Brucellosis Vaccine Product and Services
 Table 106. Jinyu Baoling Live Brucellosis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 107. Jinyu Baoling Recent Developments/Updates
 Table 108. Jinyu Baoling Competitive Strengths & Weaknesses
 Table 109. Biovet Basic Information, Manufacturing Base and Competitors
 Table 110. Biovet Major Business
 Table 111. Biovet Live Brucellosis Vaccine Product and Services
 Table 112. Biovet Live Brucellosis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 113. Biovet Recent Developments/Updates
 Table 114. Biovet Competitive Strengths & Weaknesses
 Table 115. CAVAC Basic Information, Manufacturing Base and Competitors
 Table 116. CAVAC Major Business
 Table 117. CAVAC Live Brucellosis Vaccine Product and Services
 Table 118. CAVAC Live Brucellosis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 119. CAVAC Recent Developments/Updates
 Table 120. CAVAC Competitive Strengths & Weaknesses
 Table 121. VETAL Basic Information, Manufacturing Base and Competitors
 Table 122. VETAL Major Business
 Table 123. VETAL Live Brucellosis Vaccine Product and Services
 Table 124. VETAL Live Brucellosis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 125. VETAL Recent Developments/Updates
 Table 126. VETAL Competitive Strengths & Weaknesses
 Table 127. Indian Immunologicals Basic Information, Manufacturing Base and Competitors
 Table 128. Indian Immunologicals Major Business
 Table 129. Indian Immunologicals Live Brucellosis Vaccine Product and Services
 Table 130. Indian Immunologicals Live Brucellosis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 131. Indian Immunologicals Recent Developments/Updates
 Table 132. Indian Immunologicals Competitive Strengths & Weaknesses
 Table 133. Dollvet Basic Information, Manufacturing Base and Competitors
 Table 134. Dollvet Major Business
 Table 135. Dollvet Live Brucellosis Vaccine Product and Services
 Table 136. Dollvet Live Brucellosis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 137. Dollvet Recent Developments/Updates
 Table 138. Dollvet Competitive Strengths & Weaknesses
 Table 139. Hester Biosciences Basic Information, Manufacturing Base and Competitors
 Table 140. Hester Biosciences Major Business
 Table 141. Hester Biosciences Live Brucellosis Vaccine Product and Services
 Table 142. Hester Biosciences Live Brucellosis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 143. Hester Biosciences Recent Developments/Updates
 Table 144. Hester Biosciences Competitive Strengths & Weaknesses
 Table 145. Qilu Animal Health Basic Information, Manufacturing Base and Competitors
 Table 146. Qilu Animal Health Major Business
 Table 147. Qilu Animal Health Live Brucellosis Vaccine Product and Services
 Table 148. Qilu Animal Health Live Brucellosis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 149. Qilu Animal Health Recent Developments/Updates
 Table 150. Qilu Animal Health Competitive Strengths & Weaknesses
 Table 151. Auleon Biologicals Basic Information, Manufacturing Base and Competitors
 Table 152. Auleon Biologicals Major Business
 Table 153. Auleon Biologicals Live Brucellosis Vaccine Product and Services
 Table 154. Auleon Biologicals Live Brucellosis Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 155. Auleon Biologicals Recent Developments/Updates
 Table 156. Auleon Biologicals Competitive Strengths & Weaknesses
 Table 157. Global Key Players of Live Brucellosis Vaccine Upstream (Raw Materials)
 Table 158. Global Live Brucellosis Vaccine Typical Customers
 Table 159. Live Brucellosis Vaccine Typical Distributors


List of Figures
 Figure 1. Live Brucellosis Vaccine Picture
 Figure 2. World Live Brucellosis Vaccine Production Value: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Live Brucellosis Vaccine Production Value and Forecast (2019-2030) & (USD Million)
 Figure 4. World Live Brucellosis Vaccine Production (2019-2030) & (K Units)
 Figure 5. World Live Brucellosis Vaccine Average Price (2019-2030) & (US$/Unit)
 Figure 6. World Live Brucellosis Vaccine Production Value Market Share by Region (2019-2030)
 Figure 7. World Live Brucellosis Vaccine Production Market Share by Region (2019-2030)
 Figure 8. North America Live Brucellosis Vaccine Production (2019-2030) & (K Units)
 Figure 9. Europe Live Brucellosis Vaccine Production (2019-2030) & (K Units)
 Figure 10. China Live Brucellosis Vaccine Production (2019-2030) & (K Units)
 Figure 11. Japan Live Brucellosis Vaccine Production (2019-2030) & (K Units)
 Figure 12. Live Brucellosis Vaccine Market Drivers
 Figure 13. Factors Affecting Demand
 Figure 14. World Live Brucellosis Vaccine Consumption (2019-2030) & (K Units)
 Figure 15. World Live Brucellosis Vaccine Consumption Market Share by Region (2019-2030)
 Figure 16. United States Live Brucellosis Vaccine Consumption (2019-2030) & (K Units)
 Figure 17. China Live Brucellosis Vaccine Consumption (2019-2030) & (K Units)
 Figure 18. Europe Live Brucellosis Vaccine Consumption (2019-2030) & (K Units)
 Figure 19. Japan Live Brucellosis Vaccine Consumption (2019-2030) & (K Units)
 Figure 20. South Korea Live Brucellosis Vaccine Consumption (2019-2030) & (K Units)
 Figure 21. ASEAN Live Brucellosis Vaccine Consumption (2019-2030) & (K Units)
 Figure 22. India Live Brucellosis Vaccine Consumption (2019-2030) & (K Units)
 Figure 23. Producer Shipments of Live Brucellosis Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
 Figure 24. Global Four-firm Concentration Ratios (CR4) for Live Brucellosis Vaccine Markets in 2023
 Figure 25. Global Four-firm Concentration Ratios (CR8) for Live Brucellosis Vaccine Markets in 2023
 Figure 26. United States VS China: Live Brucellosis Vaccine Production Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 27. United States VS China: Live Brucellosis Vaccine Production Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Live Brucellosis Vaccine Consumption Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. United States Based Manufacturers Live Brucellosis Vaccine Production Market Share 2023
 Figure 30. China Based Manufacturers Live Brucellosis Vaccine Production Market Share 2023
 Figure 31. Rest of World Based Manufacturers Live Brucellosis Vaccine Production Market Share 2023
 Figure 32. World Live Brucellosis Vaccine Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 33. World Live Brucellosis Vaccine Production Value Market Share by Type in 2023
 Figure 34. Strain RB-51
 Figure 35. Strain S19
 Figure 36. Strain S2
 Figure 37. Strain A19
 Figure 38. Strain Rev. I
 Figure 39. World Live Brucellosis Vaccine Production Market Share by Type (2019-2030)
 Figure 40. World Live Brucellosis Vaccine Production Value Market Share by Type (2019-2030)
 Figure 41. World Live Brucellosis Vaccine Average Price by Type (2019-2030) & (US$/Unit)
 Figure 42. World Live Brucellosis Vaccine Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 43. World Live Brucellosis Vaccine Production Value Market Share by Application in 2023
 Figure 44. Cattle
 Figure 45. Sheep
 Figure 46. Pig
 Figure 47. Others
 Figure 48. World Live Brucellosis Vaccine Production Market Share by Application (2019-2030)
 Figure 49. World Live Brucellosis Vaccine Production Value Market Share by Application (2019-2030)
 Figure 50. World Live Brucellosis Vaccine Average Price by Application (2019-2030) & (US$/Unit)
 Figure 51. Live Brucellosis Vaccine Industry Chain
 Figure 52. Live Brucellosis Vaccine Procurement Model
 Figure 53. Live Brucellosis Vaccine Sales Model
 Figure 54. Live Brucellosis Vaccine Sales Channels, Direct Sales, and Distribution
 Figure 55. Methodology
 Figure 56. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

CZ Vaccines
MSD
Ceva
Colorado Serum
Tecnovax
Syva
Shchelkovo Biocombinat
Jinyu Baoling
Biovet
CAVAC
VETAL
Indian Immunologicals
Dollvet
Hester Biosciences
Qilu Animal Health
Auleon Biologicals

Related Reports

Global Live Brucellosis Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Live Brucellosis Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 13 Dec 2024

date Agriculture

According to our (Global Info Research) latest study, the global Live Brucellosis Vaccine market size was valued at US$ 194 million in 2023 and is forecast to a readjusted size of USD 253 million by 2030 with a CAGR of 4.1% during review period.

Product Tags

Live Brucellosis Vaccine

Ornamental Freshwater Fish

Polyamide 613 Powder

Brassica Seed

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>